MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.
Precision BioSciences
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Tecvayli: New Drug for Multiple Myeloma
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
